P-Glycoprotein/MDR1 regulates pokemon gene transcription through p53 expression in human breast cancer cells

International Journal of Molecular Sciences

Volumn 11, Issue 9, 2010, Pages 3039-3051

  He, Shengnan ^a,b   Liu, Feng ^a   Xie, Zhenhua ^a   Zu, Xuyu ^a   Xu, Wei ^b   Jiang, Yuyang ^a,c  

^a TSINGHUA UNIVERSITY   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^c Tsinghua University   (China)

Author keywords

Breast cancer; P53; Pgp (MDR1); Pokemon

Indexed keywords

GLYCOPROTEIN P; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN P53; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR POKEMON; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; MULTIDRUG RESISTANCE PROTEIN; ZBTB7A PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL; CELL STRAIN MCF 7; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DRUG TARGETING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INHIBITION KINETICS; NONHUMAN; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; GENETICS; MCF 7 CELL LINE; METABOLISM; PGP (MDR1); POKEMON;

BREAST CANCER; P53; PGP (MDR1); POKEMON;

DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MCF-7 CELLS; P-GLYCOPROTEIN; PROTEIN BINDING; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77958472044     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms11093039     Document Type: Article

References (32)

1. Xia, W.; Zhao, T.; Lv, J.; Xu, S.; Shi, J.; Wang, S.; Han, X.; Sun, Y. Celecoxib enhanced the sensitivity of cancer cells to anticancer drugs by inhibition of the expression of P-glycoprotein through a COX-2-Independent Manner. J. Cell. Biochem. 2009, 108, 181-194.
2. Riordan, J.R.; Deuchars, K.; Kartner, N.; Alon, N.; Trent, J.; Ling, V. Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines. Nature 1985, 316, 817-819.
3. Ambudkar, S.; Kimchi-Sarfaty, C.; Sauna, Z.; Gottesman, M. P-glycoprotein: From genomics to mechanism. Oncogene 2003, 22, 7468-7485.
4. Fojo, A.; Cornwell, M.; Cardarelli, C.; Clark, D.; Richert, N.; Shen, D.; Ueda, K.; Willingham, M.; Gottesman, M.; Pastan, I. Molecular biology of drug resistance. Breast Cancer Res. Tr. 1987, 9, 5-16.
5. Schinkel, A.H. The physiological function of drug-transporting P-glycoproteins. Semin. Cancer Biol. 1997, 8, 161-170.
6. Johnson, D.; Finch, R.; Lin, Z.; Zeiss, C.; Sartorelli, A. The pharmacological phenotype of combined multidrug-resistance mdr1a/1b-and mrp1-deficient mice. Cancer Res. 2001, 61, 1469-1476.
7. Maeda, T.; Hobbs, R.; Pandolfi, P. The transcription factor Pokemon: A new key player in cancer pathogenesis. Cancer Res. 2005, 65, 8575-8578.
8. Maeda, T.; Hobbs, R.; Merghoub, T.; Guernah, I.; Zelent, A.; Cordon-Cardo, C.; Teruya- Feldstein, J.; Pandolfi, P. Role of the proto-oncogene pokemon in cellular transformation and ARF repression. Nature 2005, 433, 278-285.
9. Zhao, Z.; Wang, S.; Yu, L.; Ju, W.; Chang, H.; Yan, W.; Fu, K.; Zhang, J. Expression of transcription factor Pokemon in non-small cell lung cancer and its clinical significance. Chin. Med. J. 2008, 121, 445-449.
10. Deng, Y.; Ni, B.; Jiang, M.; Yang, D.; Li, F.; Wu, Y. Inhibition of proliferation of human Hela cells by small interference RNA against Pokemon gene. Chin. J. Cancer Res. 2008, 20, 5-11.
11. Jeon, B.; Yoo, J.; Choi, W.; Lee, C.; Yoon, H.; Hur, M. Proto-oncogene FBI-1 (Pokemon/ZBTB7A) represses transcription of the tumor suppressor Rb gene via binding competition with Sp1 and recruitment of co-repressors. J. Biol. Chem. 2008, 283, 33199-33210.
12. Lee, D.; Kang, J.; Park, H.; Kim, M.; Yim, T.; Kim, J.; Heo, M.; Kim, K.; Kwon, H.; Hur, M. FBI-1 enhances transcription of the nuclear factor-{kappa} B (NF-{kappa} B)-responsive E-selectin gene by nuclear localization of the p65 subunit of NF-{kappa} B. J. Biol. Chem. 2005, 280, 27783-27791.
13. Laudes, M.; Bilkovski, R.; Oberhauser, F.; Droste, A.; Gomolka, M.; Leeser, U.; Udelhoven, M.; Krone, W. Transcription factor FBI-1 acts as a dual regulator in adipogenesis by coordinated regulation of cyclin-A and E2F-4. J. Mol. Med. 2008, 86, 597-608.
14. Choi, W.; Jeon, B.; Yun, C.; Kim, P.; Kim, S.; Choi, K.; Kim, S.; Hur, M. Proto-oncogene FBI-1 represses transcription of p21CIP1 by inhibition of transcription activation by p53 and Sp1. J. Biol. Chem. 2009, 284, 12633-12644.
15. Levine, A. p53, the cellular gatekeeper for growth and division. Cell 1997, 88, 323-331.
16. Bartek, J.; Lukas, J. Pathways governing G1/S transition and their response to DNA damage. FEBS Lett. 2001, 490, 117-122.
17. Taylor, W.; Stark, G. Regulation of the G2/M transition by p53. Oncogene 2001, 20, 1803-1815.
18. Ko, L.; Prives, C. p53: Puzzle and paradigm. Gene. Dev. 1996, 10, 1054-1072.
19. Vogelstein, B.; Lane, D.; Levine, A. Surfing the p53 network. Nature 2000, 408, 307-310.
20. Grinkevich, V.; Nikulenkov, F.; Shi, Y.; Enge, M.; Bao, W.; Maljukova, A.; Gluch, A.; Kel, A.; Sangfelt, O.; Selivanova, G. Ablation of key oncogenic pathways by RITA-Reactivated p53 is required for efficient apoptosis. Cancer Cell. 2009, 15, 441-453.
21. Thottassery, J.; Zambetti, G.; Arimori, K.; Schuetz, E.; Schuetz, J. p53-dependent regulation of MDR1 gene expression causes selective resistance to chemotherapeutic agents. Proc. Natl. Acad. Sci. USA 1997, 94, 11037-11042.
22. Liu, F.; Xie, Z.; Cai, G.; Jiang, Y.Y. The effect of survivin on multidrug resistance mediated by Pglycoprotein in MCF-7 and its adriamycin resistant cells. Biol. Pharm. Bull. 2007, 30, 2279-2283.
23. Zu, X.; Ma, J.; Liu, H.X.; Liu, F.; Tan, C.Y.; Y, L.L.; W, J.; Xie, Z.H.; Cao, D.L.; Jiang, Y.Y. Pro-oncogene pokemon promotes breast cancer progression via upregulating survivin expression. Clin. Cancer Res. 2010, submitted.
24. Zu, X.Y.; Yu, L.L.; Sun, Q.S.; Liu, F.; Wang, J.; Xie, Z.H.; Wang, Y.; Xu, W.; Jiang, Y.Y. SP 1 enhances Zbtb 7 A gene expression via direct binding to GC box in HePG 2 cells. BMC Res. Not. 2009, 2, 175-181.
25. Leonard, G.; Fojo, T.; Bates, S. The role of ABC transporters in clinical practice. Oncologist 2003, 8, 411-424.
26. Avendano, C.; Carlos, M. Inhibitors of multidrug resistance to antitumor agents (MDR). Curr. Med. Chem. 2002, 9, 159-193.
27. Babakhanian, K.; Bendayan, M.; Bendayan, R. Localization of P-glycoprotein at the nuclear envelope of rat brain cells. Biochem. Bioph. Res. Commun. 2007, 361, 301-306.
28. Munteanu, E.; Verdier, M.; Grandjean-Forestier, F.; Stenger, C.; Jayat-Vignoles, C.; Huet, S.; Robert, J.; Ratinaud, M. Mitochondrial localization and activity of P-glycoprotein in doxorubicinresistant K562 cells. Biochem. Pharmacol. 2006, 71, 1162-1174.
29. Solazzo, M.; Fantappiè, O.; Lasagna, N.; Sassoli, C.; Nosi, D.; Mazzanti, R. Pgp localization in mitochondria and its functional characterization in multiple drug-resistant cell lines. Exp. Cell Res. 2006, 312, 4070-4078.
30. Bendayan, R.; Ronaldson, P.; Gingras, D.; Bendayan, M. In situ localization of P-glycoprotein (ABCB1) in human and rat brain. J. Histochem. Cytochem. 2006, 54, 1159-1167.
31. Maeda, T.; Ito, K.; Merghoub, T.; Poliseno, L.; Hobbs, R.; Wang, G.; Dong, L.; Maeda, M.; Dore, L.; Zelent, A. LRF is an essential downstream target of GATA1 in erythroid development and regulates BIM-dependent apoptosis. Dev. Cell. 2009, 17, 527-540.
32. Dyer, B.; Ferrer, F.; Klinedinst, D.; Rodriguez, R. A noncommercial dual luciferase enzyme assay system for reporter gene analysis. Anal. Biochem. 2000, 282, 158-161.